Smad1 (fosfo Ser464) Antilichaam

Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD) .

4086

Q15797

NP_001003688.1

Human, Mouse, Rat

Smad1 (Phospho-Ser465) antibody was raised against a peptide sequence around phosphorylation site of serine 465 (I-S-S-V-S (p) ) derived from Human Smad1.

Unconjugated

Primary Antibodies

Phospho-Specific

Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Phospho-Specific

Blue Ice

Store antibody at -20˚ C for up to one year.

55 kDa

This antibody detects endogenous level of Smad1 only when phosphorylated at serine 465.

Western Blot: 1:500~1:1000

SMAD1

SMAD family member 1

Homo sapiens

Hiroaki Seto, et al. (2004) J Clin Invest. March 1; 113 (5) : 718–726Linyu Li, et al. (2004) Mol Cell Biol. January; 24 (2) : 856–864. Claire Nourry, et al. (2004) BMC Cell Biol. 5: 20

BSP1, JV41, BSP-1, JV4-1, MADH1, MADR1, ERBB, ERBB1, HER1, BSP1, Dwarfin-A, Dwf-A

WB

51173727

Liquid